Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

pS343/pS345-APLNR (phospho-Apelin Receptor Antibody)

NEW
Agonist-induced Serine343/Serine345 phosphorylation of the Apelin Receptor
$ 375.00 *

Prices plus VAT plus shipping costs

Ready to ship today,
Delivery time appr. 5-8 days

  • 7TM0036B
  • 100 µl
  • Rabbit
Serine343/Serine345 (S343/S345) is major phosphorylation site of the Apelin Receptor (APLNR).... more

Serine343/Serine345 (S343/S345) is major phosphorylation site of the Apelin Receptor (APLNR). The pS343/pS345-APLNR antibody detects phosphorylation in response to agonists. S343/S345 phosphorylation is likely to be involved in efficient ligand sequestration by APLNR.

  Alternative Names APLNR, Angiotensin Receptor-like 1 IUPHAR Target... more

 

Alternative Names APLNR, Angiotensin Receptor-like 1
IUPHAR Target ID  36
UniProt ID  P35414
Western Blot (WB)  1:1000
Species Reactivity   Human
Host / Isotype Rabbit / IgG
Class Polyclonal
Immunogen A synthetic phosphopeptide derived from human APLNR around the phosphorylation site of Ser343/Ser345.
Form  Liquid
Purification Antigen affinity chromatography
Storage buffer Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide
Storage conditions short-term 4°C, long-term -20°C
Figure 1. Agonist-induced Serine343/Serine345 phosphorylation of the Apelin Receptor. Upper... more

Figure 1. Agonist-induced Serine343/Serine345 phosphorylation of the Apelin Receptor. Upper panel, HEK293 cells stably expressing the Apelin Receptor (APLNR) were either not exposed or exposed to 100 nM Apelin for 30 minutes. Cells were lysed and immunoblotted with the anti-pS343/pS345-APLNR antibody (7TM0036B) at a dilution of 1:1000. Lower panel, blot was stripped and reprobed with an phosphorylation-independent anti-APLNR antibody to confirm equal loading of the gel.

Read, write and discuss reviews... more
Customer evaluation for "pS343/pS345-APLNR (phospho-Apelin Receptor Antibody)"
Write an evaluation
Evaluations will be activated after verification.

The fields marked with * are required.

Recently viewed